Nasalferon: Nasal pharmaceutical solution, containing recombinant human interferon alpha 2b

Proyectos Nasalferon: Nasal pharmaceutical solution, containing recombinant human interferon alpha 2b

About us

The Center for Genetic Engineering and Biotechnology (CIGB), based in Cuba, is a distinctive company of Cuban biotechnology, which develops, produces, markets and exports innovative products.

Interested links

Biocubafarma
MINSAP
MINCEX
CNEURO

Outstanding news

Mambisa: nasally-administered COVID-19 vaccine candidate
Purity and efficacy of Mambisa, the first anti-covid nasal vaccine (Part I)

Social networks

Report adverse events

farmacovigilancia@cigb.edu.cu

Conditions of use
Privacy Policy
Site Map

Nasalferon: Nasal pharmaceutical solution, containing recombinant human interferon alpha 2b

Mambisa: nasally-administered COVID-19 vaccine candidate

Purity and efficacy of Mambisa, the first anti-covid nasal vaccine (Part I)